// App-Quantinova.ai

2520 : Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World

Researchers

Presenter

  • Michelle Teo

Principal Investigators

  • Derek Haaland

  • John Kelsall

  • Isabelle Fortin

  • Pauline Boulos

  • Raman Rai

  • Sanjay Dixit

  • B Haraoui

  • Dalton Sholter

  • Eliofotisti Psaradellis

  • Emmanouil Rampakakis

  • Brendan Osborne

  • Francois Nantel

  • Allen J Lehman

Medical Centers

  • Balfour Medical Clinic, Penticton, BC, Canada

  • Rheumatology, Clinical Immunology & Allergy, McMaster University, Barrie, ON, Canada

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Centre de Rhumatologie de -Est du Quebec, Rimouski, QC, Canada

  • Rheumatology, McMaster University, Hamilton, ON, Canada

  • Private Practice, Burlington, ON, Canada

  • Rheumatology, McMaster University, Hamilton, ON, Canada

  • Institut de Recherche en Rhumatologie de Montreal, Montreal, Canada

  • Rheumatology Associates, Edmonton, AB, Canada

  • JSS Medical Research, Montreal, QC, Canada

  • Medical Affairs, Janssen Inc., Toronto, ON, Canada

  • Janssen Inc., Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Ustekinumab

  • Infliximab

  • golimumab

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved